Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 3)

v3.22.4
STOCKHOLDERS EQUITY (DEFICIT) (Details 3) - Registered Warrant - 5.50
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Exercise price range 5.50
Number of exercisable Register warrant 2,975,497
Number of exercisable options 2,975,497
Weighted average exercise price exercisable term 1 year 6 months
Weighted average exercise price exercisable | $ / shares $ 5.50